Tectonic Therapeutic | AVRO - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Akebia Therapeutics USD 173.88M 10.95M 2026-03
Alnylam Pharmaceuticals USD 1.35B 116.87M 2026-03
Celltrion KRW 283.62B 3.72T 2025-12
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 38.28M 7.55M 2026-03
Divis Laboratories Ltd INR 17.28B 2.76B 2025-09
Gilead Sciences USD 9.48B 2.34B 2026-03
Ionis Pharmaceuticals USD 717M 66M 2026-03
Kangmei Pharma CNY 5.81B 57.93M 2025-09
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
MacroGenics USD 95.94M 52.82M 2026-03
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Organigram Holdings CAD 94.05M 32.11M 2025-12
Ovoca Bio EUR 186K 2.26M 2025-06
Pfizer USD 34.35B 2.64B 2026-03
Pharma Mar EUR 89.23M 4.65M 2026-03
Qiagen NV USD 512.14M 461.26M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 30.01B 1.66B 2026-03
Sarepta Therapeutics USD 499.16M 596.13M 2026-03
Sartorius EUR 2.11B 145.8M 2026-03
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Takeda JPY 2.43T 180.65B 2026-03
Tilray USD 259.32M 8.32M 2025-09
Zealand Pharma A/S 664.96M 513.61M 2025-12
Zz Pientze Pharmaceu CNY 2.28B 134.52M 2026-03